Negotiable
The date of payment from buyers deliver within days
Chongqing
Long-term effective
2021-12-06 01:55
223
Company Profile
Chongqing PSK-Health Sci-Tech Development Co., LtdBy certification [File Integrity]
Contact:psk888(Mr.)
Email:
Telephone:
Phone:
Area:Chongqing
Address:Chongqing
Website:http://www.cneecp.com/ http://psk888.0356meishi.com/
Our meta-analysis suggested that 85% of the patients those underwent EECP therapy improved by at least 1 CCS class immediately post-EECP treatment. The CCS angina class is a relatively minor predictor of prognosis and freedom from events, so our results are noteworthy and the studies evaluated long-term benefit of EECP therapy are warranted. Currently, EECP treatment provides a safe, well-tolerated, valuable option for patients who were unresponsive to maximal medical management and/or invasive therapy. Of note, in combination with other antianginal drugs, the FDA approved Ranolazine to treatment for chronic angina in 2002.
Operation Environment
Ambient temperature: 10°C~30°C;
Relative humidity: less than 85%;
Atmospheric pressure (absolute pressure): 70kPa~106kPa;
Well ventilated and free of dust, corrosive gases and strong electromagnetic interference.
http://www.cneecp.com/